Skip to main content
. 2024 Dec 27;17(1):59. doi: 10.3390/nu17010059
2-AG 2-arachidonoylglycerol
AEA Anandamide
AKI Acute kidney injury
AMI Acute myocardial infarction
ARA Arachidonic acid
ATN Acute tubular necrosis
CB Cannabinoid receptor
CB1 Cannabinoid receptor 1
CB2 Cannabinoid receptor 2
CBC Cannabichromene
CBD Cannabidiol
CBE Cannablesoin,
CBG Cannabigerol
CBL Cannabicyclol
CBM Cannabinoid-based medication
CBN Cannabinol
CBND Cannabinodiol
CBT Cannabitriol
CGRP Calcitonin gene-related peptide
CKD Chronic kidney disease
CNS Central nervous system
COX Cyclooxygenase
CUD Cannabis use disorder
CYP Cytochrome P450
DAG DIacyloglycerol
DM Diabetes mellitus
DN Diabetic nephropathy
ERKs Extracellular signal-regulated kinases
eGFR Estimated glomerular filtration rate
FAAH Fatty acid amide hydrolase
FXR Farnesoid X receptor
GFR Glomerular filtration rate
GPCR G protein coupled receptor
IR Ischemia and reperfusion
JNKs C-Jun N-terminal kinases
LPS Lipopolysaccharide
MAPK Mitogen-activated protein kinase
NADA N-arachidonoyl dopamine
NAPE N-arachidonoyl phosphatidylethanolamine
PIP2 4,5-bisphosphate
PE Phosphatidylethanolamine
PPAR Peroxisome proliferator-activated receptor
PLC Phospholipase C
SCs Synthetic cannabinoids
THC Delta-9-tetrahydrocannabinol
TLR Toll-like receptor
TRPV1 Transient receptor potential cation channel vanilloid 1
Δ8-THC Δ8 -trans-tetrahydrocannabinol
11-OH-THC 11-Hydroxy-Δ9-tetrahydrocannabinol
11-COOH-THC 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol
7-OH-CBD 7-Hydroxy-CBD